BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25572154)

  • 1. Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas.
    Miller DL; Davis JW; Taylor KH; Johnson J; Shi Z; Williams R; Atasoy U; Lewis JS; Stack MS
    Am J Pathol; 2015 Mar; 185(3):679-92. PubMed ID: 25572154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
    Hufbauer M; Maltseva M; Meinrath J; Lechner A; Beutner D; Huebbers CU; Akgül B
    Int J Cancer; 2018 Sep; 143(6):1426-1439. PubMed ID: 29663357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma: A bioinformatics study.
    Wang J; Xi X; Shang W; Acharya A; Li S; Savkovic V; Li H; Haak R; Schmidt J; Liu X; Deng Y; Pan H; Obradovic D; Schmalz G; Ziebolz D; Hu X
    Am J Otolaryngol; 2019; 40(4):547-554. PubMed ID: 31036418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
    Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas.
    Gao G; Wang J; Kasperbauer JL; Tombers NM; Teng F; Gou H; Zhao Y; Bao Z; Smith DI
    BMC Cancer; 2019 Apr; 19(1):352. PubMed ID: 30975103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A let-7 microRNA polymorphism in the KRAS 3'-UTR is prognostic in oropharyngeal cancer.
    De Ruyck K; Duprez F; Ferdinande L; Mbah C; Rios-Velazquez E; Hoebers F; Praet M; Deron P; Bonte K; Speel EJ; Libbrecht L; De Neve W; Lambin P; Thierens H
    Cancer Epidemiol; 2014 Oct; 38(5):591-8. PubMed ID: 25127693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA Oncoimmune Phenotyping of HPV-Positive p16-Positive Oropharyngeal Squamous Cell Carcinomas by Nodal Status.
    Stepp WH; Farquhar D; Sheth S; Mazul A; Mamdani M; Hackman TG; Hayes DN; Zevallos JP
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):967-975. PubMed ID: 29710215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas.
    Biron VL; Mohamed A; Hendzel MJ; Alan Underhill D; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S65-70. PubMed ID: 22569052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell cycle-related proteins in oropharyngeal squamous cell carcinoma based on human papilloma virus status.
    Tsuchida K; Sugai T; Uesugi N; Ishida K; Matsuura K; Sato I; Shiga K; Sato H
    Oncol Rep; 2017 Aug; 38(2):908-916. PubMed ID: 28627689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Functional Splice Variant of
    Guo T; Sakai A; Afsari B; Considine M; Danilova L; Favorov AV; Yegnasubramanian S; Kelley DZ; Flam E; Ha PK; Khan Z; Wheelan SJ; Gutkind JS; Fertig EJ; Gaykalova DA; Califano J
    Cancer Res; 2017 Oct; 77(19):5248-5258. PubMed ID: 28733453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.
    Kylmä AK; Tolvanen TA; Carpén T; Haglund C; Mäkitie A; Mattila PS; Grenman R; Jouhi L; Sorsa T; Lehtonen S; Hagström J
    Exp Mol Pathol; 2020 Jun; 114():104435. PubMed ID: 32240617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis.
    Huebbers CU; Verhees F; Poluschkin L; Olthof NC; Kolligs J; Siefer OG; Henfling M; Ramaekers FCS; Preuss SF; Beutner D; Seehawer J; Drebber U; Korkmaz Y; Lam WL; Vucic EA; Kremer B; Klussmann JP; Speel EM
    Int J Cancer; 2019 May; 144(10):2465-2477. PubMed ID: 30367463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV+ oropharyngeal squamous cell carcinomas from patients with two tumors display synchrony of viral genomes yet discordant mutational profiles and signatures.
    Faden DL; Langenbucher A; Kuhs K; Lewis JS; Mirabello L; Yeager M; Boland JF; Bass S; Steinberg M; Cullen M; Lawrence MS; Ferris RL
    Carcinogenesis; 2021 Feb; 42(1):14-20. PubMed ID: 33075810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
    Rodrigo JP; Heideman DA; García-Pedrero JM; Fresno MF; Brakenhoff RH; Díaz Molina JP; Snijders PJ; Hermsen MA
    Int J Cancer; 2014 Jan; 134(2):487-92. PubMed ID: 23824638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mate pair sequencing of oropharyngeal squamous cell carcinomas reveals that HPV integration occurs much less frequently than in cervical cancer.
    Gao G; Johnson SH; Kasperbauer JL; Eckloff BW; Tombers NM; Vasmatzis G; Smith DI
    J Clin Virol; 2014 Mar; 59(3):195-200. PubMed ID: 24440282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma.
    Yuan Y; Sturgis EM; Zhu L; Lu M; Li Y; Wei Q; Li G
    Mol Carcinog; 2017 Mar; 56(3):1100-1106. PubMed ID: 27677255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
    Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer.
    Božinović K; Sabol I; Dediol E; Milutin Gašperov N; Manojlović S; Vojtechova Z; Tachezy R; Grce M
    Sci Rep; 2019 Feb; 9(1):2306. PubMed ID: 30783190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm.
    Rietbergen MM; Leemans CR; Bloemena E; Heideman DA; Braakhuis BJ; Hesselink AT; Witte BI; Baatenburg de Jong RJ; Meijer CJ; Snijders PJ; Brakenhoff RH
    Int J Cancer; 2013 Apr; 132(7):1565-71. PubMed ID: 22949073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.